Browsing by Author Ametller, Elisabet

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)
21-May-2015Comparison of methods for the isolation of human breast epithelial and myoepithelial cells.Zubeldia Plazaola, Arantzazu; Ametller, Elisabet; Mancino, Mario; Prats de Puig, Miquel; López Plana, Anna; Guzman, Flavia; Vinyals, Laia; Pastor Arroyo, Eva M.; Almendro Navarro, Vanessa; Fuster Orellana, Gemma; Gascón, Pere
10-Dec-2015Differential expression of neurogenes among breast cancer subtypes identifies high risk patients.Fernandez-Nogueira, Patricia; Bragado, Paloma; Almendro Navarro, Vanessa; Ametller, Elisabet; Ríos, José; Choudhury, Sibgat; Mancino, Mario; Gascón, Pere
23-Jan-2014Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular Diversity.Almendro Navarro, Vanessa; Cheng, Yu-Kan; Randles, Amanda; Itzkovitz, Shalev; Marusyk, Andriy; Ametller, Elisabet; Gonzalez-Farre, Xavier; Muñoz Mateu, Montserrat; Russnes, Hage G.; Helland, Åslaug; Rye, Inga H.; Borresen-Dale, Anne-Lise; Maruyama, Reo; Oudenaarden, Alexander van; Dowsett, Mitchell; Jones, Robin L.; Reis-Filho, Jorge; Gascón, Pere; Gönen, Mithat; Michor, Franziska; Polyak, Kornelia
Nov-2013Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.Garcia Recio, Susana; Fuster Orellana, Gemma; Fernandez-Nogueira, Patricia; Pastor Arroyo, Eva M.; Yeong Park, So; Mayordomo, Cristina; Ametller, Elisabet; Mancino, Mario; Gonzalez-Farre, Xavier; Russnes, Hage G.; Engel Rocamora, Pablo; Costamagna, Domiziana; Fernandez, Pedro L.; Gascón, Pere; Almendro Navarro, Vanessa
15-Aug-2020The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer.López Plana, Anna; Fernández Nogueira, Patricia; Muñoz Guardiola, Pau; Solé Sánchez, Sònia; Megías Roda, Elisabet; Pérez-Montoyo, Hector; Jauregui, Patricia; Yeste Velasco, Marc; Gómez Ferreria, Mariana; Erazo, Tatiana; Ametller, Elisabet; Recalde Percaz, Leire; Moragas Garcia, Núria; Noguera Castells, Aleix; Mancino, Mario; Morán, Teresa; Nadal, Ernest; Alfón, José; Domènech, Carles; Gascon, Pere; Lizcano, José Miguel; Fuster Orellana, Gemma; Bragado Domingo, Paloma
6-Mar-2009The Role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatinAlmendro Navarro, Vanessa; Ametller, Elisabet; Garcia Recio, Susana; Collazo, Olga; Casas, Ignasi; Augé Fradera, Josep Maria; Maurel Santasusana, Joan; Gascón, Pere
7-Nov-2019Tumor Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 ActivationFernández Nogueira, Patricia; Mancino, Mario; Fuster Orellana, Gemma; López Plana, Anna; Jauregui, Patricia; Almendro Navarro, Vanessa; Enreig, Estel; Menéndez, Silvia; Rojo, Federico; Noguera Castells, Aleix; Bill, Anke; Gaither, L. Alex; Serrano, Laia; Recalde Percaz, Leire; Moragas Garcia, Núria; Alonso, Raul; Ametller, Elisabet; Rovira, Ana; Lluch, Ana; Albanell Mestres, Joan; Gascon, Pere; Bragado Domingo, Paloma
2010Tumor promoting effects of CD95 signalling in chemoresistant cellsAmetller, Elisabet; Garcia-Recio, Susana; Costamagna, Domiziana; Mayordomo, Cristina; Fernandez-Nogueira, Patricia; Carbó Carbó, Neus; Pastor Arroyo, Eva M.; Gascón, Pere; Almendro Navarro, Vanessa